Combination of PSMA targeting alpha-emitting radioligand [212Pb]Pb-AB001 with BET bromodomain inhibitors in in vitro prostate cancer models
Med Oncol, 42 (8), 362
DOI 10.1007/s12032-025-02925-9, PubMed 40694184
Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma
Haematologica (in press)
DOI 10.3324/haematol.2024.287047, PubMed 40241574
Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy
Sci Rep, 14 (1), 28805
DOI 10.1038/s41598-024-80263-y, PubMed 39567630